Literature DB >> 1663818

Autoradiography of atrial natriuretic peptide (ANP) receptors in the rat brain.

J M Saavedra1, M Kurihara.   

Abstract

Quantitative autoradiography was used to localize and characterize atrial natriuretic peptide (ANP) receptors in the rat brain and to study their regulation. Peptide receptors are selectively located to circumventricular organs outside the blood brain barrier, such as the subfornical organ, and to brain areas involved in fluid and cardiovascular regulation. Dehydration, either by water deprivation of normal rats, or chronic dehydration present in homozygous Brattleboro rats lacking vasopressin, results in large increases in ANP binding in receptor number in the subfornical organ. In the deoxycorticosterone acetate (DOCA)-salt hypertensive model, only salt treatment, but not DOCA alone or the combination of DOCA-salt, increased the ANP receptor number in the subfornical organ and the choroid plexus. Both young and adult genetically hypertensive rats have a greatly decreased ANP receptor number in the subfornical organ and the choroid plexus. Selective displacement with an inactive analog lacking the disulfide bond (ANP 111-126) suggests that genetically hypertensive rats may lack C (clearance) atrial natriuretic peptide receptors. Our results implicate brain atrial natriuretic peptide receptors in the central response to alterations in fluid regulation and blood pressure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663818     DOI: 10.1139/y91-233

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  2 in total

1.  Multiplicity of cerebrospinal fluid functions: New challenges in health and disease.

Authors:  Conrad E Johanson; John A Duncan; Petra M Klinge; Thomas Brinker; Edward G Stopa; Gerald D Silverberg
Journal:  Cerebrospinal Fluid Res       Date:  2008-05-14

Review 2.  Natriuretic hormones in brain function.

Authors:  Anastasia Hodes; David Lichtstein
Journal:  Front Endocrinol (Lausanne)       Date:  2014-11-28       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.